POPULARITY
Elevate your startup's narrative with Chrissy Farr, a renowned health tech journalist and investor. In this Masterclass, members of StartUp Health's Health Moonshot Communities had a chance to interact directly with Farr, Managing Director at Manatt Health, and health tech investor, advisor, and author of Second Opinion. Farr has impressive communications savvy and a deep understanding of the health industry and emerging trends, with an emphasis on the intersection of health and venture capital. She provides a range of go-to-market, fundraising / investor relations, social media strategy, content development and communications counsel to both emerging and established companies as well as the investors behind them. In this insightful episode, you'll learn: The power of storytelling in shaping your company's future How to craft compelling narratives that resonate with investors and the media Leveraging AI tools like ChatGPT for effective communication Balancing founder time between operations and communications Quantifying the impact of your communications efforts The role of social media in your strategy This episode is a must-listen for any health tech founder looking to refine their messaging and build a stronger brand. Tune in now to unlock the secrets of effective storytelling! Do you want to attend Masterclasses live and ask your questions of experts? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
What if receiving a medical diagnosis was as simple as shopping online? The growing home diagnostics industry says it can be. At-home testing was widespread during the COVID-19 pandemic, but more health tech companies also offer DIY kits that test for food allergies, fertility and thyroid function, among other things. Some medical experts are wary of this on-demand model, but health tech investors say it can make health care more accessible. Marketplace's Lily Jamali spoke to Chrissy Farr, author of the Second Opinion newsletter, and Anarghya Vardhana, a partner at the Maveron venture firm, about the prospects of the industry and how it affects relationships between patients and doctors.
What if receiving a medical diagnosis was as simple as shopping online? The growing home diagnostics industry says it can be. At-home testing was widespread during the COVID-19 pandemic, but more health tech companies also offer DIY kits that test for food allergies, fertility and thyroid function, among other things. Some medical experts are wary of this on-demand model, but health tech investors say it can make health care more accessible. Marketplace's Lily Jamali spoke to Chrissy Farr, author of the Second Opinion newsletter, and Anarghya Vardhana, a partner at the Maveron venture firm, about the prospects of the industry and how it affects relationships between patients and doctors.
What if receiving a medical diagnosis was as simple as shopping online? The growing home diagnostics industry says it can be. At-home testing was widespread during the COVID-19 pandemic, but more health tech companies also offer DIY kits that test for food allergies, fertility and thyroid function, among other things. Some medical experts are wary of this on-demand model, but health tech investors say it can make health care more accessible. Marketplace's Lily Jamali spoke to Chrissy Farr, author of the Second Opinion newsletter, and Anarghya Vardhana, a partner at the Maveron venture firm, about the prospects of the industry and how it affects relationships between patients and doctors.
Marketing and communications play a critical role in securing investment and driving product and service adoption in digital health. In this special two-part episode, Steve Kraus explores the art of storytelling in healthcare with two industry experts: Chrissy Farr, a veteran digital health journalist turned venture capitalist and advisor, and Kate Cronin, Chief Brand Officer at Moderna. They discuss:-What makes for a great story in digital health-The importance of including setbacks and challenges in company narratives-The undervaluing of marketing and communications roles-Strong digital health brands such as Livongo, PillPack, and Bobbie-Chief Brand Officers vs. Chief Marketing Officers-Lessons learned from rapidly scaling Moderna's brand during the COVID-19 pandemic-The importance of internal communicationsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Late last month, Change Healthcare, a unit of UnitedHealth, came under attack by an infamous hacker group called BlackCat. $22 million in ransom later, reportedly paid in bitcoin, and the problem is far from solved. Also this week: Max, previously HBO Max, announces a crackdown on password sharing — maybe it’s time to dust off the old DVD player. But first, Apple on Monday got hit with a massive fine from regulators in Europe. They say the company used its app store dominance to box out music streaming services competing with its own. What’s $2 billion to the tech titan of Cupertino? Marketplace’s Lily Jamali asked Chrissy Farr, a health tech investor at OMERS Ventures, for today’s episode of Marketplace Tech Bytes.
Late last month, Change Healthcare, a unit of UnitedHealth, came under attack by an infamous hacker group called BlackCat. $22 million in ransom later, reportedly paid in bitcoin, and the problem is far from solved. Also this week: Max, previously HBO Max, announces a crackdown on password sharing — maybe it’s time to dust off the old DVD player. But first, Apple on Monday got hit with a massive fine from regulators in Europe. They say the company used its app store dominance to box out music streaming services competing with its own. What’s $2 billion to the tech titan of Cupertino? Marketplace’s Lily Jamali asked Chrissy Farr, a health tech investor at OMERS Ventures, for today’s episode of Marketplace Tech Bytes.
Host Halle Tecco talks with two of her favorite long-time colleagues in digital health: Chrissy Farr and Malay Gandhi.Chrissy started her career in this space as a digital health reporter for VentureBeat, FastCompany, and CNBC before becoming a venture capitalist at OMERS ventures.Malay started his career in management consulting before joining me at Rock Health where he served as Managing Director and CEO before going onto be an EIR at Greylock Partners, an executive at Eviction Health, and now Head of Strategy & Corporate Development at Benching.The episode transcript is available here at http://www.heartofhealthcarepodcast.com/episodes/chrissy-farr-malay-gandhiVisit the Heart of Healthcare website for more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Welcome to the ACO Show. Today, Josh is joined by Chrissy Farr, a former tech journalist and now Principal Investor at OMERS Ventures, and Dr. Jonathan Slotkin, Chief Medical Officer at Contigo Health. Our guests share their skepticism of value-based care and how to engage high-cost medical specialists in outcomes-based arrangements.
Randi Zuckerberg dives into talk Health and Wellness trends for 2022, ways in which we can better ourselves and prioritize mental health, and how we can be remarkable in these times! Randi talks with Chrissy Farr, Health-tech investor at OMERS Ventures about health tech trends including mental health and women's health; Payal Kadakia, the founder of revolutionary fitness and wellness platform, ClassPass, about her new book, LIFEPASS, and how we can rise to our potential; and Guy Kawasaki, the chief evangelist of Canva and former chief evangelist of Apple about the current landscape of entrepreneurship.
In this episode, we meet Chrissy Farr, Principal at OMERS Ventures. Previously, she was a writer and frequent on-air contributor for CNBC, Fast Company and Reuters News, among other publications. She was raised in London, UK, and received degrees from University College London and Stanford University. Over the last five years, OMERS Ventures has invested more than $340 million of capital in nearly 30 disruptive technology companies across North America, creating over 5,000 jobs, and attracting an additional $1.2 billion for portfolio companies. Their portfolio companies include: 360insights, AmpMe, Busbud, Citizen Hex, D2L, DCG, Fusebill, Hootsuite, Hopper, Interaxon, Jobber, Kaleo, Klipfolio, Klue, Leafsift, League, Mojix, Nudge, Ranovus, Rover, Shopify (IPO 2015 — NYSE & TSX: SHOP), Smile.io, Vidyard, Vision Critical, Wattpad, Wave. Chrissy continues to write and share her perspectives here: https://ovsecondopinion.substack.com/ In this episode, Chrissy and I chat about: Chrissy's personal story: from her time at Stanford to her experiences as a journalist and her love for research, learning and connecting with innovators Her approach to investing and thesis development, areas of digital health which are underserved/overlooked and opportunities in women's health Digital health superlatives — Chrissy's takes on the most disruptive healthcare company of the year, most interesting merger/acquisition, innovative early-stage start-up to follow, and her favorite news sources Predictions for digital health in 2022, reflections and words of wisdom
This week on the podcast we sat down with Chrissy Farr, a HealthTech Investor at OMERS Ventures, where she focuses on women's health and behavioral health. In this interactive chat, Chrissy talked about her priorities for the remainder of the year, including focus areas of women's and behavioral health, as well as her experience making the change from being a full time journalist covering the health-tech beat at major publications like CNBC and Fast Company, to a venture capitalist, and how that has impacted her view on company storytelling. She also gave the inside scoop on OMERS Ventures and how to position yourself to get on her, and the broader company's, radar. Entrepreneurs: How to get investment from StartUp Health startuphealth.com Investors: How to invest in StartUp Health Moonshots healthmoonshots.com Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Laurie McGraw is speaking with Inspiring Woman Chrissy Farr, a San Francisco-based health-tech investor with a background in journalism. Chrissy is a Principal at OMERS Ventures having joined in 2020 and is focused ...
After news broke that meditation app Headspace and on-demand mental health care platform Ginger were merging, we couldn't resist hopping on the mics to do a bonus episode. And, because we were in the mood for hot takes, Natasha and Alex held the conversation on Twitter Spaces. The special guests we had on, who we'll get to down below, did not disappoint.It's a quick show, but the tl;dr is that you want to listen if you're curious why a meditation app would get into therapy, the precedent by Lyra Health and Calm, and how consolidation looks for the sector going forward.Here's who helped us understand and contextualize the news:Lux Capital partner Deena Shakir (who is also coming to Disrupt, incidentally)Chrissy Farr of OMERS Ventures (who you may also know as a former CNBC reporter in the healthech space)7WireVentures' Alyssa Jaffee (who needs her own podcast because she was shining during the Spaces)And, special shout out to Ginger CEO Russell Glass, who joined the Space but wasn't able to come up on stage due to technical difficulties. Twitter Spaces are fun, but the platform is still a bit nascent so goofs can bedevil live production.However, we managed to get some notes from him via email, so let's take a quick look at those:Glass said that he agreed with "what Chrissy Farr and others said about there simply not being enough therapists in the market today to meet the overwhelming demand," adding that there's "real global need today for what Headspace Health can offer - a scaled, comprehensive platform that can truly democratize mental healthcare."He also doubleclicked on the discussing regarding future "meaningful market consolidation," noting that he expects to see it "especially" happen in "areas that address higher acuity care for severe mental illness.”Make sure you are following the podcast on Twitter so that you catch us when we go live. These are meant to be spontaneous pop up shows, so your best bet is to turn on notifications to never miss our Spaces. Ok that's all. Thanks everyone!
After news broke that meditation app Headspace and on-demand mental health care platform Ginger were merging, we couldn't resist hopping on the mics to do a bonus episode. And, because we were in the mood for hot takes, Natasha and Alex held the conversation on Twitter Spaces. The special guests we had on, who we'll get to down below, did not disappoint.It's a quick show, but the tl;dr is that you want to listen if you're curious why a meditation app would get into therapy, the precedent by Lyra Health and Calm, and how consolidation looks for the sector going forward.Here's who helped us understand and contextualize the news:Lux Capital partner Deena Shakir (who is also coming to Disrupt, incidentally)Chrissy Farr of OMERS Ventures (who you may also know as a former CNBC reporter in the healthech space)7WireVentures' Alyssa Jaffee (who needs her own podcast because she was shining during the Spaces)And, special shout out to Ginger CEO Russell Glass, who joined the Space but wasn't able to come up on stage due to technical difficulties. Twitter Spaces are fun, but the platform is still a bit nascent so goofs can bedevil live production.However, we managed to get some notes from him via email, so let's take a quick look at those:Glass said that he agreed with "what Chrissy Farr and others said about there simply not being enough therapists in the market today to meet the overwhelming demand," adding that there's "real global need today for what Headspace Health can offer - a scaled, comprehensive platform that can truly democratize mental healthcare."He also doubleclicked on the discussing regarding future "meaningful market consolidation," noting that he expects to see it "especially" happen in "areas that address higher acuity care for severe mental illness.”Make sure you are following the podcast on Twitter so that you catch us when we go live. These are meant to be spontaneous pop up shows, so your best bet is to turn on notifications to never miss our Spaces. Ok that's all. Thanks everyone!
On today's episode of InsideOut, I'm joined by guest Chrissy Farr, Principal at OMERS Ventures along with guest co-host Dr. Jonathan Slotkin, Chief Medical Officer at Contigo Health a Premier company, to talk about all things healthcare investing. What makes Farr's perspective unique—and definitely worth the listen—is because she's newer to the investing world, having spent her career covering healthcare and recently the COVID pandemic. Most important to Farr's strategy, though? Transparency, in both journalism and investments.
In this episode, former journalist Chrissy Farr joins me to discuss 2020, including reporting on a pandemic, attacks on the media, the most unbelievable stories of the year and her new role at OMERS Ventures. Intro :13 About Farr :17 The interview 1:01 How did you end up in journalism? 1:08 What was it like being a journalist in 2020? 2:47 How did you figure out what to focus on when covering the pandemic? 7:09 Were you concerned you might publish a story that would need a retraction? 9:22 Is this the first time you’ve dealt with targeted attempts to discredit the media? 19:00 Comments from readers, patients 24:02 Journalists are in the category of “hero” 25:45 Looking back at 2020, are there any stories that seemed unbelievable? 27:41 Did you notice that politics and other topics became more intertwined with your health reporting? 32:21 It’s interesting how people change the narrative based on their agenda 35:49 Tell us about your new role with OMERS Ventures 39:44 What made you leave journalism? 42:08 Farr’s take-home message 45:15 Thank you, Chrissy 47:09 Christina (Chrissy) Farr is principal investor, Health-Tech Lead at OMERS Ventures and a former journalist. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Farr can be reached @chrissyfarr. Follow us on Twitter @HemOncToday @ShikhaJainMD. Disclosures: Jain reports she is a paid freelance writer for Lippincott. Farr is principal investor at OMERS Ventures.
The biggest news event of the week was Apple's virtual WWDC keynote, during which the company showed off a ton of upcoming features to its various software products. In Devindra's absence, Cherlynn is joined by Dan Cooper as guest co-host, as well as senior mobile editor Chris Velazco to rip into Apple's latest updates. From iOS 14 vs Android, to watchOS 7, to macOS and Apple's transition to ARM chips, there's plenty to discuss. Then, our hosts are joined by CNBC's health and health-tech reporter Chrissy Farr to talk about the latest developments in healthcare and telemedicine. Do wearable companies have the right idea when it comes to developing products for COVID-19? What is Apple's approach to this burgeoning industry? This Was Maybe the Biggest WWDC in Years? – 1:41 Siri, Maps, and App Clips – 13:38 iPadOS Gets an Update – 24:03 New Horizons in Telehealth with CNBC's Chrissy Farr – 42:17 Can Wearables Help Predict COVID-19 (Don't Bet on It) – 45:44
This episode of 16 Minutes on the news covers:FICO credit score changes, what are they, do they matter? -- with a16z fintech general partners Angela Strange and Anish Acharya;electronic health record provider Epic's letter urging hospitals to oppose government regulations that would make it easier for patients and companies to access medical information, and where is the Plaid of healthcare? -- at 10:19 with a16z bio general partner Julie Yoo;...in conversation with Sonal Chokshi.Background links / pieces mentioned in this episode:Changes are coming to your credit score, Anna Bahney, CNN BusinessFICO changes could lower your credit score, AnnaMaria Andriotis, Wall Street JournalEpic’s CEO is urging hospital customers to oppose rules that would make it easier to share medical info & Epic and about 60 hospital chains come out against rules that would make it easier to share medical info, Chrissy Farr, CNBCHealth care data-sharing rules touch off intense lobbying fight, Darius Tahir, Politico ---The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets) is available at https://a16z.com/investments/.Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.
Jennifer Esposito, Former General Manager of Health & Life Sciences, Intel chats with Christina Farr, Technology and Healthcare Reporter, CNBC on "How Tech Companies Think About Health Innovation" at the 2019 StartUp Health Festival in San Francisco, California
Wellness, fitness, nutrition – all of it is getting a makeover in this age of mobile tech. Now you can book doctor appointments on an app, get your blood drawn and the results back in 20 minutes. You can give your doctor access to your genetic code and get truly personalized service. Your stationary bike can connect to the Internet to motivate you. But how much is too much? And what are the best services to check out? We have got just the show to kick off the year, whether you do resolutions or not. Joining me today, CNBC reporters Chrissy Farr and Diana Olick. And I’m thrilled to have WW CEO Mindy Grossman here with me. What’s WW? It’s the artist formerly known as Weight Watchers. Learn more about your ad choices. Visit megaphone.fm/adchoices
As the tech titans push forward with their entrance into healthcare, speculation surrounds their chances of successfully solving the industry's myriad of maladies. Hear from Cleveland Clinic CEO-turned-Googler Dr. Toby Cosgrove and CNBC.com's Chrissy Farr on what's notable—and what's just noise—as these tech giants move into the $3T healthcare market.
Robert Mittendorff, MD, partner at Norwest Venture Partners, and Bill Geary, co-founder and partner at Flare Capital Partners, review the highlights of the successful Digital Healthcare Innovation Summit held on October 11 in Boston.In this interview they discuss:The most important takeaway from the State of Healthcare by Sam Baker of Axios.An important address by Andy Slavitt of Town Hall Ventures (and speculation as to where the new firm will invest).The advances in Digital Therapeutics and Telehealth.The one technology leader traveling under the Digital Health radar.Two conversations led by CNBC’s Chrissy Farr.Start-ups working to manage patient financial responsibility.The meeting was broadcast live on Twitter. Go to the pinned tweet @dhisummit.More content on the way.
Three new iPhone Xs and a watch that's a cleared medical device: That's what Apple announced at its biggest event of the year. But what does it mean for Apple? Which, if any, of this stuff is worth buying? Jon Fortt breaks it down with Christina Farr, CNBC.com health reporter who has been breaking stories left and right on Apple's health advancements; Jillian Manus, Silicon Valley venture capitalist, and CNBC tech correspondent Josh Lipton. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of Sequenced, Vinod Khosla, renowned Silicon Valley entrepreneur and investor, sits down with CNBC’s Chrissy Farr to discuss how technology will reinvent healthcare as we know it.
In the inaugural “A Healthy Dose” podcast, Trevor and Steve get Ambar Bhattacharyya, Manager Director at Maverick Ventures, Sean Duffy, CEO of Omada Health, and Chrissy Farr, healthcare and technology journalist at Fast Company, together for a roundtable discussion to recap the 2017 JP Morgan Healthcare Conference. The group reflects on the climate of healthcare following the presidential election and the investment trends.
The President-elect vowed to repeal the ACA on his first day in office. Or will he just pick it apart and keep the pieces he likes? The water is murky and answers are forthcoming, but we can be certain of one thing—a shift in healthcare legislation as we move from a Democratic to Republican House. Bill Evans, Rock Health's Managing Director, recently interviewed James Robinson from the UC Berkeley School of Public Health and Christina Farr from Fast Company in order to frame the key questions to be asking at this time.